Enzolytics Inc (ENZC)

[moolamoola]

both Regeneron and Lilly got FDA approval to use Monoclonal...however they don't got ENZC has...the silver bullet!! ---->

$ENZC stock of the year, check out the highlighted from Nov 13 news, Lilly has been granted FDA approval for their #Monoclonal but #enzc has propriety methodology producing antibodies targeting virus immutable sites, Lilly needs $ENZC, its the SILVER BULLET! #hugepharmapartners🔥 https://t.co/Ika4xzJuBq pic.twitter.com/ZzeP298f3P

— MoolaMoola 🍥 (@tripsmoolamoola) November 22, 2020